Combiclav Lactating Cow Intramammary Suspension (pack of 24)

Target species: Lactating cattle. Indications for use, specifying the target species For the treatment of clinical mastitis caused by the following bacteria susceptible to the combination of amoxicillin and clavulanic acid: •Staphylococci (including β-lactamase producing strains) •Streptococci (including S. agalactiae, S. dysgalactiae and S. uberis) •Escherichia coli (including β-lactamase producing strains) Contraindications Do not use in cases of hypersensitivity to the active substances, or to any of the excipients. Special Warnings for each target species Do not use in cases associated with Pseudomonas Special precautions for use Special precautions for use in animals Swab teat end before treatment, with cleaning towels provided. Recommendations for prudent use The product should be used for treatment of clinical mastitis only. Use of the product should be based on susceptibility testing of the bacteria isolated from the animal. If this is not possible, therapy should be based on local (regional, farm level) epidemiological information about susceptibility of the target bacteria. Official, national and regional antimicrobial policies should be taken into account when the product is used. The combination of amoxicillin and clavulanic acid should be reserved for the treatment of clinical conditions which have responded poorly, or are expected to respond poorly, to other classes of antimicrobials. Avoid use of the product in herds where no β-lactamase producing staphylococci strains have been isolated. E.coli mastitis with mild to moderate clinical signs, a non-antimicrobial approach should be the first option. Veterinarians should strive to use narrow spectrum antibiotics if possible. Inappropriate use of the product may increase the prevalence of bacteria resistant to β-lactam antibiotics and may decrease the effectiveness of treatment with β-lactam antibiotics, due to the potential for cross-resistance. Most of the ESBLs and AmpC β-lactamases producing E.coli strains may not be inhibited by the combination of amoxicillin/clavulanic acid. The feeding of waste milk containing residues of antibiotics to calves should be avoided up to the end of the milk withdrawal period, except during colostral phase, because it could select antimicrobial resistant bacteria within the intestinal microbiota of the calf and increase the faecal shedding of these bacteria. Special precautions to be taken by the person administering the veterinary medicinal product to animals This product may cause skin and eye irritation. Avoid contact with the skin and eyes. In the event of skin or eye contact rinse with plenty of clean water. The cleaning towels supplied with the product contain isopropyl alcohol, which many cause skin or eye irritation in some people. The wearing of gloves is recommended during administration of the product and when handling the cleaning towels. Penicillins and cephalosporins may cause hypersensitivity (allergy) following injection, inhalation, ingestion, or skin contact. Hypersensitivity to penicillins may lead to cross reactions to cephalosporins and vice versa. Allergic reactions to these substances may occasionally be serious. Do not handle this product if you know you are sensitised, or if you have been advised not to work with such preparations. Handle this product with great care to avoid exposure, taking all recommended precautions. If you develop symptoms following exposure such as a skin rash, you should seek medical advice and show the doctor this warning. Swelling of the face, lips or eyes or difficulty with breathing, are more serious symptoms and require urgent medical attention. Wash hands after use. Other precautions Due to the endocrine-disrupting potential of prednisolone, the product may be dangerous to fish and other aquatic organisms. Consequently treated animals should not have access to watercourses during the first 12 hours after treatment. Adverse reactions (frequency and seriousness) In very rare cases, immediate hypersensitivity reactions may occur (less than 1 animal in 10,000 animals treated, including isolated reports). Use during pregnancy, lactation or lay No special precautions Interaction with other medicinal products and other forms of interaction None known
Vat Rate: 20%